AEON.WS

AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

52 hedge funds and large institutions have $5.62M invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
4
Reduced
6
Closed
8
Calls
$1.01M
Puts
Net Calls
+$1.01M
Net Calls Change
+$19K
Name Holding Trade Value Shares
Change
Shares
Change %
UOC
51
UBS O'Connor
Illinois
-$8K -112,473 Closed
Verition Fund Management
52
Verition Fund Management
Connecticut
-$7K -100,000 Closed
MF
53
Magnetar Financial
Illinois
-$5K -61,159 Closed
AGM
54
Alpine Global Management
New York
-$3K -50,100 Closed
LOAMU
55
Lombard Odier Asset Management (USA)
New York
-$3K -41,666 Closed
ESCM
56
Echo Street Capital Management
New York
-$2K -33,333 Closed
Susquehanna International Group
57
Susquehanna International Group
Pennsylvania
-$1K -17,009 Closed
TCM
58
Tegean Capital Management
New York
-$1K -14,000 Closed